Ya‐Wen Yang

发表

Cigarette smoking may modify the risk of depression in eczema among adults: a preliminary study using NHANES 2005–2006

Y.‐H. Chen, Ya‐Wen Yang, Y. H. Chen, 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

Incidence, mortality, and causes of death of patients with pemphigus in Taiwan: a nationwide population-based study.

Yu-Huei Huang, C. Kuo, Yi-Hua Chen, 2012, The Journal of investigative dermatology.

Increased Risk of Stroke in Patients With Bullous Pemphigoid: A Population-Based Follow-Up Study

Sudha Xirasagar, Herng-Ching Lin, Yi-Hua Chen, 2011, Stroke.

SF‐36 healty survey on psoriasis quality‐of‐life: A study of 414 Taiwanese patients

J. Lu, Yu-Huei Huang, Chih-hsun Yang, 2015, The Journal of dermatology.

Cutaneous reactive angiomatosis associated with cholesterol embolism

Chi-Long Chen, Kuo‐Hsien Wang, Ya‐Wen Yang, 2010, Journal of cutaneous pathology.

Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study

Yi-Hua Chen, Kuo-Hsien Wang, Hui-Wen Lin, 2011, Canadian Medical Association Journal.

Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma

Shang‐Yi Huang, Hsuan-Yu Lin, S. Yeh, 2018, Hematological oncology.

Psoriasis and pregnancy outcomes: a nationwide population-based study.

Herng‐Ching Lin, Yi-Hua Chen, C. Chen, 2011, Journal of the American Academy of Dermatology.

Colocolonic intussusception with a leading point.

Jin-Tung Liang, Ya‐Wen Yang, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Intra-abdominal mass after abdominal surgery.

Jin-Ming Wu, Jin-Tung Liang, Ya‐Wen Yang, 2009, Gastroenterology.

Increased risk of psoriasis following obstructive sleep apnea: a longitudinal population-based study.

Herng‐Ching Lin, Jiunn-Horng Kang, Ya‐Wen Yang, 2012, Sleep medicine.

Consistent safety profile with up to five years of continuous treatment with guselkumab: pooled analyses from the phase 3 VOYAGE 1 and VOYAGE 2 trials of patients with moderate-to-severe psoriasis.

K. Papp, Y. You, A. Blauvelt, 2021, Journal of the American Academy of Dermatology.

Cutaneous Plasmacytosis -Report of a Case-

Sindy Hu, T. Kuo, H. Hong, 2003 .

Safety of Guselkumab Treatment for up to 5 Years in Patients With Moderate-to-Severe Psoriasis: Pooled Analyses Across Seven Clinical Trials With Greater Than 8600 Patient-Years of Exposure.

M. Lebwohl, Y. You, J. Merola, 2023, British Journal of Dermatology.

Malignancy Rates Through 5 Years of Follow-up in Patients With Moderate-to-Severe Psoriasis Treated With Guselkumab: Pooled Results From the VOYAGE 1 and VOYAGE 2 Trials.

M. Lebwohl, K. Papp, P. Foley, 2023, Journal of American Academy of Dermatology.

Guselkumab for the treatment of patients with moderate‐to‐severe hidradenitis suppurativa: A phase 2 randomized study

A. Kimball, K. Papp, Chenglong Han, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.